Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Stephen Harvey Zinner, M.D.

Concepts

This page shows the publications Stephen Zinner has written about Kinetics.
Connection Strength

0.147
  1. Time inside the mutant selection window as a predictor of staphylococcal resistance to linezolid. J Antibiot (Tokyo). 2018 05; 71(5):514-521.
    View in: PubMed
    Score: 0.024
  2. Effect of dose and schedule on cefoperazone pharmacodynamics in an in vitro model of infection in a neutropenic host. Am J Med. 1988 Jul 25; 85(1A):56-8.
    View in: PubMed
    Score: 0.013
  3. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrob Agents Chemother. 1987 Jul; 31(7):1054-60.
    View in: PubMed
    Score: 0.012
  4. Pharmacokinetics and pharmacodynamics of intravenous ciprofloxacin. Studies in vivo and in an in vitro dynamic model. Am J Med. 1987 Apr 27; 82(4A):363-8.
    View in: PubMed
    Score: 0.012
  5. Bactericidal activity of ciprofloxacin alone and in combination with azlocillin in an in-vitro capillary model. J Antimicrob Chemother. 1986 Nov; 18 Suppl D:49-54.
    View in: PubMed
    Score: 0.011
  6. In vitro models in the study of antibiotic therapy of infections in neutropenic patients. Am J Med. 1986 May 30; 80(5C):40-4.
    View in: PubMed
    Score: 0.011
  7. Laboratory support for choosing and monitoring antimicrobial therapy in severely ill patients. Am J Med. 1986 May 30; 80(5C):59-63.
    View in: PubMed
    Score: 0.011
  8. Impact of netilmicin regimens on the activities of ceftazidime-netilmicin combinations against Pseudomonas aeruginosa in an in vitro pharmacokinetic model. Antimicrob Agents Chemother. 1985 Jul; 28(1):64-8.
    View in: PubMed
    Score: 0.010
  9. Use of an in-vitro kinetic model to study antibiotic combinations. J Antimicrob Chemother. 1985 Jan; 15 Suppl A:221-6.
    View in: PubMed
    Score: 0.010
  10. Two compartment kinetic model with multiple artificial capillary units. J Antimicrob Chemother. 1985 Jan; 15 Suppl A:131-7.
    View in: PubMed
    Score: 0.010
  11. Species-independent pharmacodynamics of gemifloxacin and ciprofloxacin with Haemophilus influenzae and Moraxella catarrhalis in an in vitro dynamic model. Int J Antimicrob Agents. 2002 Sep; 20(3):201-5.
    View in: PubMed
    Score: 0.008
  12. An artificial capillary in vitro kinetic model of antibiotic bactericidal activity. J Infect Dis. 1981 Dec; 144(6):583-7.
    View in: PubMed
    Score: 0.008
  13. Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model. Antimicrob Agents Chemother. 1999 Mar; 43(3):498-502.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.